CORC  > 中国医学科学院 北京协和医学院
A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity
Jiang, Linlin; Yang, Ming; Zhang, Xiaoyun; Bao, Shiqi; Ma, Li; Fan, Dongmei; Zhou, Yuan; Xiong, Dongsheng; Zhen, Yongsu
2016
卷号24期号:1页码:47-57
关键词Anti-CD19(Fab)-LDM B-lymphoma DNA damage internalization targeted therapy
ISSN号1061-186X
DOI10.3109/1061186X.2015.1055568
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6382310
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Jiang, Linlin,Yang, Ming,Zhang, Xiaoyun,et al. A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity[J],2016,24(1):47-57.
APA Jiang, Linlin.,Yang, Ming.,Zhang, Xiaoyun.,Bao, Shiqi.,Ma, Li.,...&Zhen, Yongsu.(2016).A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity.,24(1),47-57.
MLA Jiang, Linlin,et al."A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity".24.1(2016):47-57.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace